These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7024284)
1. Patterns of antibody reactivity against selected human leukemia cell lines. Anderson MJ; Oeljeschlager H; Müller-Hermelink HK; Müller-Ruchholtz W J Cancer Res Clin Oncol; 1981; 101(1):101-7. PubMed ID: 7024284 [TBL] [Abstract][Full Text] [Related]
2. Selective antilymphocyte sera (SAL) in bone marrow transplantation. I. In vitro characterization of antihuman SAL and the development of absorption procedures using cultured cell lines. Anderson MJ; Schmitz N; Müller-Hermelink HK; Müller-Ruchholtz W Int Arch Allergy Appl Immunol; 1985; 76(3):218-25. PubMed ID: 3882571 [TBL] [Abstract][Full Text] [Related]
3. Removal of myelotoxicity from antilymphocytic sera. Gordon MY; Zola H Transplantation; 1979 Feb; 27(2):106-9. PubMed ID: 313615 [TBL] [Abstract][Full Text] [Related]
4. Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation. Marijt EA; Veenhof WF; Goulmy E; Kluck PM; Brand A; Willemze R; van Rood JJ; Falkenburg JH Hum Immunol; 1993 Aug; 37(4):221-8. PubMed ID: 8300407 [TBL] [Abstract][Full Text] [Related]
5. Specific recognition of human leukemic cells by allogeneic T cell lines. Sosman JA; Oettel KR; Hank JA; Fisch P; Sondel PM Transplantation; 1989 Sep; 48(3):486-95. PubMed ID: 2571206 [TBL] [Abstract][Full Text] [Related]
6. Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts. Borella L; Sen L; Casper JT J Immunol; 1977 Jan; 118(1):309-15. PubMed ID: 318669 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody DLC-48: an effective reagent for use in the depletion of malignant lymphoma from human bone marrow. Winter JN; Marder RJ; Radosevich JA; Epstein AL Int J Cancer; 1987 Jun; 39(6):670-7. PubMed ID: 3294609 [TBL] [Abstract][Full Text] [Related]
9. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943 [TBL] [Abstract][Full Text] [Related]
10. GM 58/8: a monoclonal antibody that identifies a new lineage-specific determinant expressed by myeloid progenitors (CFU-GM) and their progeny. Das Gupta A; Brice M; Yokochi T; Papayannopoulou T; Stamatoyannopoulos G Br J Haematol; 1984 Sep; 58(1):147-58. PubMed ID: 6205677 [TBL] [Abstract][Full Text] [Related]
11. The repopulation capacity of bone marrow grafts following pretreatment with monoclonal antibodies against T lymphocytes in rhesus monkeys. Gerritsen WR; Wagemaker G; Jonker M; Kenter MJ; Wielenga JJ; Hale G; Waldmann H; van Bekkum DW Transplantation; 1988 Feb; 45(2):301-7. PubMed ID: 3278419 [TBL] [Abstract][Full Text] [Related]
12. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon. Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352 [TBL] [Abstract][Full Text] [Related]
13. Manipulation of graft-versus-host disease for a graft-versus-leukemia effect after allogeneic bone marrow transplantation in AKR mice with spontaneous leukemia/lymphoma. Truitt RL; Shih CC; LeFever AV Transplantation; 1986 Mar; 41(3):301-10. PubMed ID: 3513389 [TBL] [Abstract][Full Text] [Related]
14. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow. Truitt RL; Atasoylu AA Bone Marrow Transplant; 1991 Jul; 8(1):51-8. PubMed ID: 1833016 [TBL] [Abstract][Full Text] [Related]
15. Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells. De Fazio S; Hartner WC; Monaco AP; Gozzo JJ J Immunol; 1985 Nov; 135(5):3034-8. PubMed ID: 2864375 [TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation after antilymphocyte globulin conditioning--split lymphocyte chimerism. Mathé G; Schwarzenberg L; Amiel JL; Schneider M; Belpomme D; Jasmin C; Rosenfeld C; Hayat M; de Vassal F; Steresco M Transplant Proc; 1972 Dec; 4(4):551-7. PubMed ID: 4566797 [No Abstract] [Full Text] [Related]
17. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55. Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266 [TBL] [Abstract][Full Text] [Related]
18. An attempt at isolation and partial characterization of specific antibodies from antithymocyte serum. Fricová V; Hrubá A; Paluska E; Holdová J Folia Biol (Praha); 1979; 25(6):353-61. PubMed ID: 42567 [TBL] [Abstract][Full Text] [Related]
19. In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen. Lamon EW; Skurzak HM; Klein E; Wigzell H J Exp Med; 1972 Nov; 136(5):1072-9. PubMed ID: 4117188 [No Abstract] [Full Text] [Related]
20. Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation. Hale G; Swirsky D; Waldmann H; Chan LC Br J Haematol; 1985 May; 60(1):41-8. PubMed ID: 3890929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]